Orthocell wins first international approval for nerve repair product
West Australia-based regenerative medicine play Orthocell (ASX: OCC) has received regulatory approval from the Health Sciences Authority in Singapore.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ANE | ane where to from here | 27/11/07 | 1 | 2.1K | |||
|
|||||||
ANE | ane has rejected the gns 6.15 takeover offer | 05/08/07 | 12 | 5.5K | |||
|
|||||||
ANE | sold to early | 17/05/07 | 3 | 1.8K | |||
|
|||||||
ANE | possible takeover | 20/04/07 | 2 | 1.7K | |||
|
|||||||
ANE | up 11 | 19/04/07 | 0 | 469 | |||
|
|||||||
ANE | plus 400 soon | 19/04/07 | 0 | 432 | |||
|
|||||||
ANE | uptrend | 10/04/07 | 0 | 418 | |||
|
|||||||
ANE | rising plus 12 | 16:38 | 1 | 1.0K | |||
|
See All Discussions